Twist Bioscience Corporation (TWST)
USD 36.93
(-3.95%)
USD 36.93
(-3.95%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -220.83 Million USD | -1.69% |
| 2023 | -217.15 Million USD | 12.79% |
| 2022 | -249.02 Million USD | -62.48% |
| 2021 | -153.26 Million USD | -30.35% |
| 2020 | -117.57 Million USD | -8.02% |
| 2019 | -108.85 Million USD | -54.27% |
| 2018 | -70.55 Million USD | -20.65% |
| 2017 | -58.48 Million USD | -33.96% |
| 2016 | -43.65 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -46.97 Million USD | 6.25% |
| 2024 Q2 | -48.88 Million USD | -4.07% |
| 2024 Q3 | -43.99 Million USD | -81.89% |
| 2023 FY | -217.15 Million USD | 12.79% |
| 2023 Q4 | -50.11 Million USD | 17.55% |
| 2023 Q2 | -62.83 Million USD | -28.85% |
| 2023 Q1 | -48.76 Million USD | 15.99% |
| 2023 Q3 | -60.78 Million USD | 3.27% |
| 2022 Q3 | -61.16 Million USD | 8.46% |
| 2022 Q4 | -58.04 Million USD | 5.1% |
| 2022 FY | -249.02 Million USD | -62.48% |
| 2022 Q1 | -55.94 Million USD | -40.51% |
| 2022 Q2 | -66.81 Million USD | -19.44% |
| 2021 FY | -153.26 Million USD | -30.35% |
| 2021 Q4 | -39.81 Million USD | 5.48% |
| 2021 Q1 | -32.79 Million USD | -36.83% |
| 2021 Q2 | -38 Million USD | -15.89% |
| 2021 Q3 | -42.11 Million USD | -10.83% |
| 2020 Q2 | -32.08 Million USD | 42.53% |
| 2020 FY | -117.57 Million USD | -8.02% |
| 2020 Q1 | -55.83 Million USD | -76.85% |
| 2020 Q4 | -23.96 Million USD | 15.0% |
| 2020 Q3 | -28.19 Million USD | 12.12% |
| 2019 Q4 | -31.56 Million USD | -12.26% |
| 2019 FY | -108.85 Million USD | -54.27% |
| 2019 Q3 | -28.12 Million USD | -7.07% |
| 2019 Q2 | -26.26 Million USD | -14.7% |
| 2019 Q1 | -22.89 Million USD | -16.2% |
| 2018 Q1 | -16.75 Million USD | -0.77% |
| 2018 Q2 | -16.61 Million USD | 0.79% |
| 2018 FY | -70.55 Million USD | -20.65% |
| 2018 Q3 | -17.48 Million USD | -5.22% |
| 2018 Q4 | -19.7 Million USD | -12.68% |
| 2017 FY | -58.48 Million USD | -33.96% |
| 2017 Q3 | -14.24 Million USD | 0.0% |
| 2017 Q4 | -16.62 Million USD | -16.73% |
| 2016 FY | -43.65 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -97.35 Million USD | -126.826% |
| Applied DNA Sciences, Inc. | -10.95 Million USD | -1916.116% |
| Aspira Women's Health Inc. | -18.85 Million USD | -1071.393% |
| Biodesix, Inc. | -41.34 Million USD | -434.157% |
| BioNexus Gene Lab Corp. | -2.59 Million USD | -8414.498% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -2669.656% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -2669.656% |
| Bionano Genomics, Inc. | -215.24 Million USD | -2.595% |
| CareDx, Inc | -101.9 Million USD | -116.713% |
| Check-Cap Ltd. | -19.28 Million USD | -1044.973% |
| Castle Biosciences, Inc. | -67.97 Million USD | -224.861% |
| DarioHealth Corp. | -56.18 Million USD | -293.015% |
| Exact Sciences Corporation | -215.01 Million USD | -2.706% |
| Fulgent Genetics, Inc. | -72.69 Million USD | -203.777% |
| Guardant Health, Inc. | -564.72 Million USD | 60.896% |
| ICON Public Limited Company | 956.15 Million USD | 123.096% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 120.128% |
| Illumina, Inc. | -1.06 Billion USD | 79.342% |
| Intelligent Bio Solutions Inc. | -10.28 Million USD | -2047.498% |
| iSpecimen Inc. | -11.16 Million USD | -1877.116% |
| Standard BioTools Inc. | -76.6 Million USD | -188.291% |
| MDxHealth SA | -27.32 Million USD | -708.106% |
| 23andMe Holding Co. | -321.35 Million USD | 31.282% |
| Medpace Holdings, Inc. | 336.82 Million USD | 165.563% |
| Myriad Genetics, Inc. | -123.7 Million USD | -78.521% |
| Mainz Biomed B.V. | -26.64 Million USD | -728.8% |
| ENDRA Life Sciences Inc. | -10.52 Million USD | -1999.007% |
| NeoGenomics, Inc. | -107.73 Million USD | -104.974% |
| Neogen Corporation | 58.66 Million USD | 476.44% |
| Inotiv, Inc. | -81.46 Million USD | -171.091% |
| Natera, Inc. | -446.24 Million USD | 50.514% |
| OpGen, Inc. | -15.68 Million USD | -1307.6% |
| OPKO Health, Inc. | -157.02 Million USD | -40.638% |
| Psychemedics Corporation | -2.92 Million USD | -7460.116% |
| Prenetics Global Limited | -52.51 Million USD | -320.522% |
| Prenetics Global Limited | -52.51 Million USD | -320.522% |
| Precipio, Inc. | -7.62 Million USD | -2798.045% |
| Personalis, Inc. | -109.93 Million USD | -100.872% |
| RadNet, Inc. | 98.69 Million USD | 323.746% |
| Sera Prognostics, Inc. | -39.82 Million USD | -454.559% |
| Sotera Health Company | 276.69 Million USD | 179.811% |
| Neuronetics, Inc. | -30.55 Million USD | -622.756% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -4981.247% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -4981.247% |
| Trinity Biotech plc | -27.04 Million USD | -716.532% |
| T2 Biosystems, Inc. | -49.66 Million USD | -344.65% |
| Exagen Inc. | -22.83 Million USD | -866.988% |